Ireland
--:--IST
Latest
Clinical Trials in Turkey / NCT07540325
Starting soon Observational

Effects of Cognitive Dual-Task on Gait in Parkinson's Disease

NCT07540325 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-04-20
Last updated
2026-04-20

Condition(s) studied

Parkinson's Disease (PD)CognitionGait Disorders

Study summary

The aim of this study is to evaluate gait in individuals diagnosed with PD under tasks involving different cognitive domains, to compare the results with those of age and sex-matched healthy individuals, and to determine which cognitive function has the greatest impact on gait in PD.

Eligibility

Sex
ALL
Min age
40 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria for Individuals with Parkinson's Disease: * A clinical diagnosis of Parkinson's Disease confirmed by a neurologist according to the United Kingdom Parkinson's Disease Society Brain Bank diagnostic criteria * Classified between stages 1 and 3 according to the Modified Hoehn and Yahr Staging Scale * Aged between 40 and 80 years * A score of at least 21 on the Montreal Cognitive Assessment (MoCA) * Ability to walk continuously for at least 10 minutes without interruption and without the use of any assistive walking device * Having received at least 5 years of formal education Exclusion Criteria for Individuals with Parkinson's Disease: * Presence of any neurological disorder other than Parkinson's Disease * Presence of any cardiopulmonary or musculoskeletal condition that may impair safe ambulation * A score of ≥10 for anxiety and ≥7 for depression on the Hospital Anxiety and Depression Scale (HADS) * Presence of visual or auditory impairments that cannot be corrected with assistive devices Inclusion Criteria for Healthy Individuals: * Aged between 40 and 80 years * A score of at least 21 on the Montreal Cognitive Assessment (MoCA) Exclusion Criteria for Healthy Individuals: * Presence of any neurological disorder * Presence of any cardiopulmonary or musculoskeletal condition that may affect safe ambulation * A score of ≥10 for anxiety and ≥7 for depression on the Hospital Anxiety and Depression Scale (HADS) * Presence of visual or auditory impairments that cannot be corrected with assistive devices

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation. Ankara Turkey (Türkiye)

More Gazi University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07540325 on ClinicalTrials.gov ↗ ← All trials in Turkey